Close

Analyst Ratings for Pasithea Therapeutics Corp. (KTTA) [Sells]

KTTA Rating Summary

KTTA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KTTA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $2.00 (-72.4%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details